L25,26 metabolic & inherited liver disease
-
Upload
mohammad-manzoor -
Category
Health & Medicine
-
view
234 -
download
2
description
Transcript of L25,26 metabolic & inherited liver disease
![Page 1: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/1.jpg)
Metabolic & Inherited Liver Diseases
Lectures 25, 26
α1-ANTITRYPSIN DEFICIENCY
![Page 2: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/2.jpg)
Metabolic Liver Disease
1.Type2 diabetes
2.Obesity3.Dyslipidemia
![Page 3: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/3.jpg)
• Hemochromatosis• Wilson disease
• α1-ANTITRYPSIN DEFICIENCY
![Page 4: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/4.jpg)
![Page 5: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/5.jpg)
• Hemochromatosis was first described by von Recklinghausen in 1889. It is characterized by the excessive accumulation of body iron, most of which is deposited in parenchymal organs such as the liver and pancreas.
![Page 6: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/6.jpg)
Primary or Heriditary Hemochromatosis
Hemochromatosis is a homozygous-recessive inherited disorder that is caused by excessive iron absorption.
![Page 7: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/7.jpg)
Secondary Hemochromatosis
• Accumulation of iron in tissues, which may occur as a consequence of parenteral administration of iron, usually in the form of transfusions, or other causes, is variably known as secondary hemochromatosis, acquired hemochromatosis, or hemosiderosis.
![Page 8: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/8.jpg)
• We will use the terms hemochromatosis for the hereditary disease and
• hemosiderosis for the acquired deposition of iron in some tissues.
![Page 9: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/9.jpg)
The total body iron pool ranges from 2 to 6 gm in normal adults; about 0.5 gm is stored in the liver, 98% of which is in hepatocytes.
In hemochromatosis, total iron accumulation may exceed 50 gm, over one third of which accumulates in the liver.
![Page 10: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/10.jpg)
Characteristic features of Hemochromatosis
• Fully developed cases exhibit• (1) micronodular cirrhosis in all patients;• (2) diabetes mellitus in 75% to 80% of
patients; and • (3) skin pigmentation in 75% to 80% of
patients.
![Page 11: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/11.jpg)
• Males predominate (5 to 7 : 1) with slightly earlier clinical presentation, partly because physiologic iron loss (menstruation, pregnancy) delays iron accumulation in women.
![Page 12: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/12.jpg)
• There are at least four genetic variants of hereditary hemochromatosis. The most common form is an autosomal recessive disease of adult onset caused by mutations in the HFE gene.
![Page 13: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/13.jpg)
Pathogenesis• In hereditary hemochromatosis there is a
defect in the regulation of intestinal absorption of dietary iron, leading to net iron accumulation of 0.5 to 1.0 gm/year.
HFE gene is resposible for this disorder.
![Page 14: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/14.jpg)
• HFE regulates the levels of hepcidin, the iron hormone produced by the liver. Hepcidin normally down-regulates the efflux of iron from the intestines and macrophages into the plasma and inhibits iron absorption.
• When hepcidin levels are reduced there is increased iron absorption.
![Page 15: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/15.jpg)
• Hereditary hemochromatosis manifests
typically after 20gm of
storage iron has accumulated.
![Page 16: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/16.jpg)
Regardless of source, excessive iron seems to be directly toxic to tissues by
the following mechanism:(1) Lipid peroxidation by iron-catalyzed free radical
reaction,(2) Stimulation of Collagen formation(3) Direct interaction of iron with DNA.Whatever the actions of iron, they may be reversible,
with the exception of nonlethal DNA damage.
![Page 17: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/17.jpg)
Morphology• 1. The deposition of hemosiderin• 2. Cirrhosis• 3. Pancreatic fibrosisThe pancreas, heart, skin, joints and testes may
also be affected.
![Page 18: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/18.jpg)
Clinical features
1. Hepatomegaly2. Abdominal Pain3. Skin Pigmentation4. Diabetes Mellitus5. Arrhythmias, cardiomyopathy6. Arthritis.
![Page 19: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/19.jpg)
• Amenorrhea• Loss of libido• Impotence• Triad of Cirrhosis (Hepatomegaly, Skin
pigmentation, DM) • Death due to: Cirrhosis, HCC, Cardiac disease
![Page 20: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/20.jpg)
• Treatment of iron overload does not remove the risk for development of HCC, because of the oxidative damage of DNA produced by iron.
![Page 21: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/21.jpg)
Diagnosis
• Serum ferritin• Liver biopsy• HFE• MRI
![Page 22: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/22.jpg)
TreatmentPhlebotomies (bloodletting)Deferoxamine
![Page 23: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/23.jpg)
Prognosis• A third of those untreated develop
hepatocellular carcinoma• The risk of HCC development in patients with
hemochromatosis is 200-fold higher than in normal populations.
![Page 24: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/24.jpg)
![Page 25: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/25.jpg)
Definition• Wilson disease is an autosomal recessive disorder
caused by mutation of the ATP7B gene, resulting in impaired copper excretion into bile and a failure to incorporate copper into ceruloplasmin.
![Page 26: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/26.jpg)
• Deficiency in the ATP7B protein causes a decrease in copper transport into bile, impairs its incorporation into ceruloplasmin, and inhibits ceruloplasmin secretion into the blood.
• These changes cause copper accumulation in the liver and a decrease in circulating ceruloplasmin.
• The copper causes toxic liver injury, through the production of ROS.
![Page 27: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/27.jpg)
Morphology
• Inflammation • Hepatocyte necrosis• Macrovesicular steatosis, • vacuolated hepatocellular nuclei, • Mallory bodies.• Cirrhosis
![Page 28: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/28.jpg)
Clinical Features.
Age between 6 and 40. The most common presentation is acute or
chronic liver disease.
![Page 29: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/29.jpg)
• Neuropsychiatric manifestations, including mild behavioral changes,
• frank psychosis, or a Parkinson disease–like syndrome (such as tremor
![Page 30: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/30.jpg)
Biochemical Diagnosis
• a decrease in serum ceruloplasmin,• an increase in hepatic copper content (the most
sensitive and accurate test), and • increased urinary excretion of copper (the most
specific screening test).
![Page 31: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/31.jpg)
• Demonstration of Kayser-Fleischer rings (green to brown deposits of copper in Desçemet's membrane in the limbus of the cornea) further favors the diagnosis.
![Page 32: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/32.jpg)
Treatment• Early recognition and• long-term copper chelation therapy (as with
D-penicillamine, or Trientine) or• zinc-based therapy. • Liver Transplantation
![Page 33: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/33.jpg)
Mamoon Manzoor Mashwani
![Page 34: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/34.jpg)
Metabolic & Inherited Liver Diseases
Part II
![Page 35: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/35.jpg)
α1-ANTITRYPSIN DEFICIENCY
α1-Antitrypsin deficiency is an autosomal recessive disorder marked by very low levels of α1-antitrypsin.
![Page 36: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/36.jpg)
![Page 37: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/37.jpg)
α1-Antitrypsin• α1-Antitrypsin is a small 394–amino acid
plasma glycoprotein synthesized predominantly by hepatocytes.
![Page 38: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/38.jpg)
![Page 39: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/39.jpg)
• The major function of this protein is the
inhibition of proteases, particularly neutrophil elastase, cathepsin G, and proteinase 3, which are normally released from neutrophils at sites of inflammation.
![Page 40: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/40.jpg)
![Page 41: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/41.jpg)
![Page 42: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/42.jpg)
α1- Antitrypsin deficiency leads to the development of:
• pulmonary emphysema,• liver disease, • cutaneous panniculitis (inflammation of subcutaneous adipose tissue) ,• arterial aneurysm, • bronchiectasis, • Wegener's granulomatosis (vasculitis)
![Page 43: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/43.jpg)
Morphology• α1-Antitrypsin deficiency is characterized by
the presence of round-to-oval cytoplasmic globular inclusions in hepatocytes, which in routine H&E stains are acidophilic and indistinctly demarcated from the surrounding cytoplasm.
![Page 44: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/44.jpg)
![Page 45: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/45.jpg)
![Page 46: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/46.jpg)
Cirrhosis
![Page 47: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/47.jpg)
![Page 48: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/48.jpg)
![Page 49: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/49.jpg)
![Page 50: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/50.jpg)
Treatment• The treatment, and the cure, for severe
hepatic disease is liver transplantation.
![Page 51: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/51.jpg)
Cholestasis is a condition where bile cannot flow from the liver to the
duodenum.
![Page 52: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/52.jpg)
Neonatal Hepatitis• Neonatal hepatitis is an
inflammation of the liver that occurs in early infancy, usually one to two months after birth.
![Page 53: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/53.jpg)
Causes of Neonatal Hepatitis
• Neonatal hepatitis mainly caused by a virus, such as hepatitis B virus, cytomegalovirus, rubella virus, herpes simplex virus and gastro-intestinal virus. Toxoplasma gondii parasite, Li Division Thac bacteria, syphilis, etc., is also one of the causes of neonatal hepatitis.
![Page 54: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/54.jpg)
NEONATAL CHOLESTASIS • Prolonged conjugated hyperbilirubinemia in the
neonate, termed neonatal cholestasis, affects approximately 1 in 2500 live births.
Cholestasis is a condition where bile cannot flow from the liver to the duodenum.
![Page 55: L25,26 metabolic & inherited liver disease](https://reader033.fdocuments.net/reader033/viewer/2022061210/549076b6b479595a358b45e0/html5/thumbnails/55.jpg)